||David Silver is Vice President, Strategy & Portfolio Management for the Pharmaceuticals segment at Covidien, Plc., a leading $10 billion global healthcare products company. The business, formerly known as Tyco Healthcare, separated from parent company Tyco International on June 29, 2007. In this position, Mr. Silver is responsible for leading portfolio management, strategic planning and analytical assessment programs for the Pharmaceuticals segment. In this role, Mr. Silver supervises product development decisions and the implementation of the strategic planning process for the segment in collaboration with Covidien's Corporate Strategic Planning organization. With more than 30 years of experience in the pharmaceutical industry, Mr. Silver joined Covidien in July 2007 from Argent Rx Solutions in Wilmington, N.C., where he counseled emerging pharmaceutical companies on strategic marketing and commercial analytics. Prior to this, he served in senior management positions at Xanodyne Pharmaceutical, AAIPharma and Elan Pharmaceuticals. He also served as the Vice President for Business Information and Analysis at Sanofi-Synthelabo Pharmaceutical. Mr. Silver received a master's degree in business administration from Rutgers University and a bachelor's degree in pharmacy from the University of Rhode Island.